Results 221 to 230 of about 3,144,476 (264)

Targeting the <i>ZMYM2-ANXA9</i> Axis with <i>FLT3</i> Inhibitor G749 Overcomes Oxaliplatin Resistance in Colorectal Cancer. [PDF]

Biomedicines
Lin D, Xu Y, Zhan H, Liang Y, Liu R, Liu J, Luo D, Chen X, Cai J, Zou Y.   +9 more
europepmc   +1 more source

CRCs-CAFs crosstalk-targeted nano-delivery system reprograms tumor microenvironment for oxaliplatin resistance reversing and liver metastasis inhibition in colorectal cancer. [PDF]

Bioact Mater
Liu H, Xu C, Wang P, Guo L, Yan X, Zhou R, Tang Y, Wang S, Chen J, Wang Q, Tian H.   +10 more
europepmc   +1 more source

ALYREF-Mediated Regulation of TBL1XR1 and KMT2E Synergistically Upregulates APOC1, Contributing to Oxaliplatin Resistance in Esophageal Cancer. [PDF]

Cancer Res Treat
Hu J, Liu Q, Feng B, Lu Y, Chen K.
europepmc   +1 more source

Correction: TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach. [PDF]

PLoS One
Cheraghi-Shavi T, Jalal R, Minuchehr Z, Mahjoubi F.   +3 more
europepmc   +1 more source

Oxygen vacancy-engineered bimetallic nanozymes for disrupting electron transport chain and synergistic multi-enzyme activity to reverse oxaliplatin resistance in colorectal cancer. [PDF]

J Nanobiotechnology
Zhong D, Yang X, Yang J, Luo Z, Feng Z, Ma M, Liao Y, Tang Y, Wen Y, Liu J, Hu S.   +10 more
europepmc   +1 more source

Cancer-Associated Fibroblasts Enhance Oxaliplatin Resistance in Colorectal Cancer Cells via Paracrine IL-6: An In Vitro Study. [PDF]

Iran J Pharm Res
Wang J, Lu Y, Wang Z, Wei P.
europepmc   +1 more source

Exploring the therapeutic potential of "Zhi-Zhen" formula for oxaliplatin resistance in colorectal cancer: an integrated study combining UPLC-QTOF-MS/MS, bioinformatics, network pharmacology, and experimental validation. [PDF]

Front Med (Lausanne)
Li Y, Chen K, Li Q, Liu Q, Han H, Liu H, Wang S.   +6 more
europepmc   +1 more source

Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation. [PDF]

PLoS One
Sahebnasagh R, Deli H, Shadboorestan A, Vakili-Ghartavol Z, Salehi N, Komeili-Movahhed T, Azizi Z, Ghahremani MH.   +7 more
europepmc   +1 more source

Gfi-1 modulates HMGB1-Mediated autophagy to overcome oxaliplatin resistance in colorectal cancer. [PDF]

Heliyon
Liu W, Zhang Z, Zhang L, Jiang X, Chen C, Wu X, Zhao Q.   +6 more
europepmc   +1 more source

APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer. [PDF]

Aging (Albany NY)
Liu YL, Xiang Z, Zhang BY, Zou YW, Chen GL, Yin L, Shi YL, Xu LL, Bi J, Wang Q.   +9 more
europepmc   +1 more source